Clik here to view.
Icosapent ethyl, イコサペント酸エチル
Icosapent ethyl 330.5042 , C22H34O2 cas 86227-47-6 / 73310-10-8 ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate Ethyl eicosapentaenoic acid イコサペント酸エチル (5Z,8Z,11Z,14Z,17Z)-Eicosapetaenoic acid...
View ArticleFDA approves first treatment Libtayo (cemiplimab-rwlc) for advanced form of...
FDA approves first treatment for advanced form of the second most common skin cancer New drug targets PD-1 pathway The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc)...
View ArticleClik here to view.
BMS 986142
BMS-986142 (2S,5R,3S)-6-fluoro-5-(3-(8-fluoro-1-methyl-2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-2-methylphenyl)-2-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide...
View ArticleClik here to view.
Molidustat, Bay 85-3934
Molidustat UNII-9JH486CZ13, cas no 1154028-82-6, MW: 314.3076 2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(triazol-1-yl)-1H-pyrazol-3-one Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors Originator...
View ArticleClik here to view.
CIFORADENANT
CIFORADENANT 1202402-40-1 Chemical Formula: C20H21N7O3 Molecular Weight: 407.434 CPI-444, CPI 444, CPI444, V81444, V-81444, V 81444, UNII 8KFO2187CP Corvus Pharmaceuticals, Inc. PHASE 1...
View ArticleClik here to view.
USFDA approval to Lumoxiti (moxetumomab pasudotoxtdfk) a new treatment for...
USFDA approval to Lumoxiti is a new treatment for hairy cell leukemia On September 13, 2018, the U.S. Food and Drug Administration approved Lumoxiti (moxetumomab pasudotoxtdfk) injection for...
View ArticleFDA approves a new drug Xofluza (baloxavir marboxil) to treat influenza
FDA approves a new drug to treat influenza Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12...
View ArticleClik here to view.
Caplacizumab, カプラシズマブ Cablivi is the first therapeutic approved in Europe,...
Cablivi is the first therapeutic approved in Europe, for the treatment of a rare blood-clotting disorder On September 03, 2018, the European Commission has granted marketing authorization for Cablivi...
View ArticleClik here to view.
Pirlindole
Pirlindole Molecular FormulaC15H18N2 Average mass226.317 Da 1H-Pyrazino[3,2,1-jk]carbazole, 2,3,3a,4,5,6-hexahydro-8-methyl- 2,3,3a,4,5,6-hexahydro-8-methyl-1h-pyrazino[3,2,1-jk]carbazole 4615...
View ArticleClik here to view.
FDA warns patients and doctors about risk of inaccurate results from home-use...
DRUG REGULATORY AFFAIRS INTERNATIONAL FDA warns patients and doctors about risk of inaccurate results from home-use device to monitor blood thinner warfarin The U.S. Food and Drug Administration today...
View ArticleClik here to view.
Statement from FDA Commissioner Scott Gottlieb, M.D., on findings from the...
DRUG REGULATORY AFFAIRS INTERNATIONAL tatement from FDA Commissioner Scott Gottlieb, M.D., on findings from the romaine lettuce E. coli O157:H7 outbreak investigation and FDA’s efforts to prevent...
View ArticleClik here to view.
FDA permits marketing of two devices that detect parathyroid tissue in...
DRUG REGULATORY AFFAIRS INTERNATIONAL FDA permits marketing of two devices that detect parathyroid tissue in real-time during surgery Today, the U.S. Food and Drug Administration permitted marketing...
View ArticleClik here to view.
Eflornithine, эфлорнитин , إيفلورنيثين , 依氟鸟氨酸 , エフロルニチン
Eflornithine DFMO, RMI-71782ATC:P01CX03, BRN 2250529 / HSDB 7923 / MDL 71782 / RFI 7178 / RMI 71782 Ornithine, 2-(difluoromethyl)- UNII:ZQN1G5V6SR ZQN1G5V6SR эфлорнитин [Russian] [INN] إيفلورنيثين...
View ArticleClik here to view.
Nemorexant
Nemorexant ACT-541468, UNII LMQ24G57E9 [(2S)-2-(5-Chloro-4-methyl-1H-benzimidazol-2-yl)-2-methyl-1-pyrrolidinyl][5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone 1505484-82-1 [RN] LMQ24G57E9...
View ArticleFDA approves new drug Aemcolo (rifamycin), to treat travelers’ diarrhea
FDA approves new drug to treat travelers’ diarrhea The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with...
View ArticleClik here to view.
Lumateperone
Lumateperone Molecular FormulaC24H28FN3O Average mass393.497 Da 4-((6bR,10aS)-3-Methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)-butan-1-one...
View ArticleFDA approves first treatment Gamifant (emapalumab) specifically for patients...
FDA approves first treatment Gamifant (emapalumab) specifically for patients with rare and life-threatening type of immune disease The U.S. Food and Drug Administration today approved Gamifant...
View ArticleFDA approves new treatment for patients with acute myeloid leukemia
FDA approves new treatment Daurismo (glasdegib) for patients with acute myeloid leukemia The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination...
View ArticleClik here to view.
Omidenepag isopropyl, オミデネパグイソプロピル
Omidenepag isopropyl DE-117 Glycine, N-(6-((((4-(1H-pyrazol-1-yl)phenyl)methyl)(3-pyridinylsulfonyl)amino)methyl)-2-pyridinyl)-, 1-methylethyl ester...
View ArticleClik here to view.
Anthony Crasto conferred ABPnews award for “Outstanding contribution to...
Conferred prestigious award at event ABP News Presents Healthcare Leadership Awards 26th November, 2018 at Taj Lands End, Mumbai India Dedicated to Shobha Crasto Aishal crasto Lionel crasto Service...
View Article